查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1947431

侧向层析检测市场：依产品、技术、应用、终端用户和地区划分 - 全球预测至 2036 年

Lateral Flow Assays Market by Product, Technique, Application, End User, and Geography-Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 194 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2026 年全球侧向层析检测 (LFA) 市场规模为 137 亿美元，预计到 2036 年将达到约 274 亿美元，预测期内（2026-2036 年）复合年增长率 (CAGR) 为 7.9%。

本报告对五大主要地区的侧向层析检测市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至 2036 年的预测。透过广泛的二级和一级研究以及对市场现状的详细分析，我们对关键产业驱动因素、限制因素、机会和挑战进行了影响分析。推动侧向层析检测市场成长的关键因素包括对快速诊断测试的需求不断增长、传染病日益普遍以及即时检测解决方案的日益普及。 此外，与数位和行动阅读器技术的整合、多重检测技术的扩展、对居家检测日益增长的重视，以及兽医诊断和食品安全领域新应用的开发，预计将为侧向流动检测市场的企业创造显着的增长机会。

市场区隔

目录

第一章：引言

第二章：研究方法

第三章：摘要整理

第四章：市场洞察

  • 驱动因素
    • 与实验室检测相比，基于侧向流动检测的快速检测的优势
    • 居家侧向流动检测的日益普及
    • 即时检测的需求不断增长检测
    • 慢性病和传染病患者病率上升
    • 智慧型装置普及率上升
  • 限制因素
    • 侧向层析检测结果的变异性
  • 机遇
    • 侧向层析侦测应用范围扩大
    • 食品饮料产业需求成长
  • 挑战
  • 诊断方法变革的阻力
  • 多重检测技术的开发

第五章 全球侧向层析检测市场（依产品分类）

  • 试剂盒和试剂
  • 侧向层析阅读器
    • 数位/行动阅读器
    • 桌上型阅读器读者

第六章：全球侧向层析检测市场（依技术划分）

  • 夹心法检测
  • 竞争法检测
  • 多重侦测

第七章：全球侧向层析检测市场（依应用划分）

  • 临床检测
    • 传染病检测
    • 怀孕与不孕症检测
    • 心臟标记检测
    • 胆固醇检测/血脂分析
    • 药物滥用检测
    • 其他临床检测
  • 兽医诊断
  • 食品安全与环境检测
  • 药物开发与品质检测

第八章：全球侧向层析检测市场（依终端用户划分）

  • 医院和诊所
  • 诊断实验室
  • 家庭医疗保健机构
  • 製药和生技公司
  • 其他终端用户

第九章：依地区划分的市场

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 拉丁美洲
  • 中东和非洲

第十章：竞争情形

  • 关键成长策略
  • 竞争标竿分析
  • 市占率分析

第11章 企业简介

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux S.A.
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Quidel Corporation
  • Merck KGaA
  • Others

第12章 附录

简介目录
Product Code: MRHC - 104471

Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036

According to the research report titled, 'Lateral Flow Assays Market by Product (Kits & Reagents, Lateral Flow Readers), Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing), End User, and Geography-Global Forecast to 2036,' the global lateral flow assays (LFA) market is valued at USD 13.7 billion in 2026 and is expected to reach approximately USD 27.4 billion by 2036, at a CAGR of 7.9% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global lateral flow assays market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The major factors driving the growth of the lateral flow assays market include increasing demand for rapid diagnostic testing, growing prevalence of infectious diseases, and widespread adoption of point-of-care testing solutions. Additionally, digital and mobile reader technology integration, multiplex detection expansion, home-based testing emphasis, and emerging application development in veterinary diagnostics and food safety are expected to create significant growth opportunities for players operating in the lateral flow assays market.

Market Segmentation

The lateral flow assays market is segmented by product (kits & reagents, lateral flow readers), technique (sandwich assays, competitive assays, multiplex detection assays), application (clinical testing, veterinary diagnostics, food safety & environment testing, drug development & quality testing), end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, kits and reagents represent the largest segment in the lateral flow assays market in 2026, attributed to the high volume of diagnostic tests performed globally and the recurring nature of kit and reagent purchases. Digital and mobile lateral flow readers are the fastest-growing product segment, providing quantitative results and eliminating subjectivity associated with visual interpretation. These readers enable data transmission to electronic health records and laboratory information systems, improving workflow efficiency.

Based on Technique

By technique, sandwich assays, competitive assays, and multiplex detection assays represent the key technical approaches in the market. Multiplex lateral flow assays capable of detecting multiple analytes simultaneously are a significant market trend, enabling comprehensive diagnostic evaluation in a single test and improving efficiency while reducing testing costs.

Based on Application

By application, clinical testing is the largest segment, driven by widespread use of rapid diagnostic tests in healthcare settings. Infectious disease testing, including tests for COVID-19, influenza, and other respiratory pathogens, represents the largest sub-segment. Emerging applications in veterinary diagnostics, food safety testing, and drug development are creating new market opportunities. Pregnancy and fertility testing, cardiac marker testing, and cholesterol screening are additional clinical applications driving market growth.

Based on End User

By end user, hospitals and clinics hold the largest share, driven by high volume of diagnostic testing performed in these settings. Home care settings are experiencing rapid growth in lateral flow assay adoption, driven by increasing emphasis on home-based testing and self-diagnostics. Diagnostic laboratories, research institutions, and veterinary clinics represent additional end-user segments.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to hold the largest market share for lateral flow assays, driven by advanced healthcare infrastructure, high healthcare spending, and strong regulatory frameworks. Europe is projected to experience steady growth, driven by supportive regulatory frameworks and adoption of point-of-care testing. Asia-Pacific is emerging as the fastest-growing region, with increasing healthcare spending, improving healthcare infrastructure, and growing awareness of diagnostic testing in countries such as China, India, and Japan.

Key Players

The key players operating in the global lateral flow assays market are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Biomerieux S.A., QIAGEN N.V., PerkinElmer, Inc., Quidel Corporation, Merck KGAA, and various other regional and emerging manufacturers, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the lateral flow assays market globally?
  • At what rate is the global lateral flow assays market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global lateral flow assays market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of product, technique, application, and end user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global lateral flow assays market?
  • Who are the major players in the global lateral flow assays market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global lateral flow assays market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Lateral Flow Assays Market Assessment -- by Product

  • Kits & Reagents
  • Lateral Flow Readers

Lateral Flow Assays Market Assessment -- by Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

Lateral Flow Assays Market Assessment -- by Application

  • Clinical Testing
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Lateral Flow Assays Market Assessment -- by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Research Institutions
  • Veterinary Clinics
  • Other End Users

Lateral Flow Assays Market Assessment -- by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Southeast Asia
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for this Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Benefits of LFA-Based Rapid Tests over Laboratory Tests
    • 4.2.2. Increasing Usage of Home-Based Lateral Flow Assays
    • 4.2.3. Growing Demand for Point-of-Care Testing
    • 4.2.4. Growing Prevalence of Chronic & Infectious Diseases
    • 4.2.5. Growing Acceptance of Smart Devices
  • 4.3. Restraints
    • 4.3.1. Variability in Lateral Flow Assay Test Results
  • 4.4. Opportunities
    • 4.4.1. Evolving Applications of Lateral Flow Assays
    • 4.4.2. Rising Demand in Food & Beverage Industry
  • 4.5. Challenges
    • 4.5.1. Reluctance Toward Changing Diagnostic Practices
    • 4.5.2. Development of Multiplexing Assays

5. Global Lateral Flow Assays Market, by Product

  • 5.1. Introduction
  • 5.2. Kits & Reagents
  • 5.3. Lateral Flow Readers
    • 5.3.1. Digital/Mobile Readers
    • 5.3.2. Benchtop Readers

6. Global Lateral Flow Assays Market, by Technique

  • 6.1. Introduction
  • 6.2. Sandwich Assays
  • 6.3. Competitive Assays
  • 6.4. Multiplex Detection Assays

7. Global Lateral Flow Assays Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Testing
    • 7.2.1. Infectious Disease Testing
    • 7.2.2. Pregnancy & Fertility Testing
    • 7.2.3. Cardiac Marker Testing
    • 7.2.4. Cholesterol Testing/Lipid Profile
    • 7.2.5. Drug Abuse Testing
    • 7.2.6. Other Clinical Tests
  • 7.3. Veterinary Diagnostics
  • 7.4. Food Safety & Environmental Testing
  • 7.5. Drug Development & Quality Testing

8. Global Lateral Flow Assays Market, by End User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Home Care Settings
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Other End Users

9. Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis

11. Company Profiles

  • 11.1. Abbott Laboratories
  • 11.2. F. Hoffmann-La Roche AG
  • 11.3. Becton, Dickinson and Company
  • 11.4. Siemens Healthineers AG
  • 11.5. Thermo Fisher Scientific, Inc.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. bioMerieux S.A.
  • 11.8. QIAGEN N.V.
  • 11.9. PerkinElmer, Inc.
  • 11.10. Quidel Corporation
  • 11.11. Merck KGaA
  • 11.12. Others

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization